Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

245 results about "Hematoma" patented technology

A hematoma (US spelling) or haematoma (UK spelling) is a localized bleeding outside of blood vessels, due to either disease or trauma including injury or surgery and may involve blood continuing to seep from broken capillaries. A hematoma is benign and is initially in liquid form spread among the tissues including in sacs between tissues where it may coagulate and solidify before blood is reabsorbed into blood vessels. An ecchymosis is a hematoma of the skin larger than 10mm.

Circumferential medical closure device and method

A flexible medical closure screen device for a separation of first and second tissue portions is provided, which includes a mesh screen comprising tubular vertical risers, vertical strands with barbed filaments, and horizontal spacers connecting the risers and strands in a grid-like configuration. An optional perimeter member partly surrounds the screen and can comprise a perimeter tube fluidically coupled with the vertical risers to form a tubing assembly. Various input / output devices can optionally be connected to the perimeter tube ends for irrigating and / or draining the separation according to methodologies of the present invention. Separation closure, irrigation and drainage methodologies are disclosed utilizing various combinations of closure screens, tubing, sutures, fluid transfer elements and gradient force sources. The use of mechanical forces associated with barbed strands for repositionably securing separated tissues together is disclosed. The use of same for eliminating or reducing the formation of subcutaneous voids or pockets, which can potentially form hematoma and seroma effects, is also disclosed. Alternative embodiments of the invention have circumferential configurations for approximating and closing separated tissue portions such as tendons, nerves and blood vessels. Tissue closure methods include the steps of circumferentially applying a screen to separated tissue portions and penetrating the tissue portions with prongs.
Owner:3M INNOVATIVE PROPERTIES CO

Internal and external medical closure screen systems and methods

An internal and external medical closure system for a separation of first and second tissue portions is provided, which includes a mesh screen comprising tubular vertical risers, vertical strands with barbed filaments, and horizontal spacers connecting the risers and strands in a grid-like configuration. An optional perimeter member partly surrounds the screen and can comprise a perimeter tube fluidically coupled with the vertical risers to form a tubing assembly. Various input / output devices can optionally be connected to the perimeter tube ends for irrigating and / or draining the separation according to methodologies of the present invention. Separation closure, irrigation and drainage methodologies are disclosed utilizing various combinations of closure screens, tubing, sutures, fluid transfer elements and gradient force sources. The use of mechanical forces associated with barbed strands for repositionably securing separated tissues together is disclosed. The use of same for eliminating or reducing the formation of subcutaneous voids or pockets, which can potentially form hematoma and seroma effects, is also disclosed. Further disclosed are alternative embodiment medical closure screen installation systems and methods.
Owner:3M INNOVATIVE PROPERTIES CO

Medical closure clip system and method

A medical closure screen device for a separation of first and second tissue portions is provided, which includes a mesh screen comprising tubular vertical risers, vertical strands with barbed filaments, and horizontal spacers connecting the risers and strands in a grid-like configuration. An optional perimeter member partly surrounds the screen and can comprise a perimeter tube fluidically coupled with the vertical risers to form a tubing assembly. Various input / output devices can optionally be connected to the perimeter tube ends for irrigating and / or draining the separation according to methodologies of the present invention. Separation closure, irrigation and drainage methodologies are disclosed utilizing various combinations of closure screens, tubing, sutures, fluid transfer elements and gradient force sources. The use of mechanical forces associated with barbed strands for repositionably securing separated tissues together is disclosed. The use of same for eliminating or reducing the formation of subcutaneous voids or pockets, which can potentially form hematoma and seroma effects, is also disclosed. The device can be fabricated and the method practiced with clips having various configurations.
Owner:3M INNOVATIVE PROPERTIES CO

Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof

Methods for the diagnosis and evaluation of stroke and stroke sub-type employ a variety of bio-markers including cellular fibronectin (c-Fn) assembled as a panel for stoke diagnosis and evaluation. Methods are disclosed for selecting markers and correlating their combined levels with a clinical outcome of interest. In various aspects the methods permit early detection and differentiation of stroke subtypes, determination of the prognosis of a patient presenting stroke symptoms, and identification of a patient at risk for early hematoma growth and / or malignant massive cerebral artery infarction. The disclosed methods provide rapid, sensitive and specific assays to greatly increase the number of patients that can receive beneficial stroke treatment and therapy, and to reduce the human and economic costs associated with incorrect stroke diagnosis.
Owner:PREDICTION SCI

Method for treatment of blood tumor using anti-TIM-3 antibody

Disclosed is a therapeutic method comprising administering a TIM-3 antibody to a subject who is suspected to be suffering from blood tumor and in whom TIM-3 has been expressed in a Lin(−)CD34(+)CD38(−) cell fraction of bone marrow or peripheral blood or a subject who has been received any treatment for blood tumor. Also disclosed is a composition for preventing or treating blood tumor, which comprises a TIM-3 antibody as an active ingredient. Conceived diseases include those diseases which can be treated through the binding or targeting of the TIM-3 antibody to blood tumor cells (AML cells, CML cells, MDS cells, ALL cells, CLL cells, multiple myeloma cells, etc.), helper T cell (e.g., Th1 cells, Th17 cells), and antigen-presenting cells (e.g., dendritic cells, monocytes, macrophages, and cells resembling to the aforementioned cells (hepatic stellate cells, osteoclasts, microglial cells, intraepidermal macrophages, dust cells (alveolar macrophages), etc)), all of which are capable of expressing TIM-3. The diseases for which the therapeutic use is to be examined include blood diseases in which the expression of TIM-3 is observed in bone marrow or peripheral blood, particularly blood tumor.
Owner:KYOWA HAKKO KIRIN CO LTD +1

Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof

InactiveUS7392140B2Convenient treatmentAdditional diagnostic and/or prognostic indicatorsMedical data miningDisease diagnosisStroke subtypeGastroenterology
Methods for the diagnosis and evaluation of stroke and stroke sub-type employ a variety of bio-markers including cellular fibronectin (c-Fn) assembled as a panel for stoke diagnosis and evaluation. Methods are disclosed for selecting markers and correlating their combined levels with a clinical outcome of interest. In various aspects the methods permit early detection and differentiation of stroke subtypes, determination of the prognosis of a patient presenting stroke symptoms, and identification of a patient at risk for early hematoma growth and / or malignant massive cerebral artery infarction. The disclosed methods provide rapid, sensitive and specific assays to greatly increase the number of patients that can receive beneficial stroke treatment and therapy, and to reduce the human and economic costs associated with incorrect stroke diagnosis.
Owner:PREDICTION SCI

Non-invasive brain injury evaluation

A non-invasive method for measuring intracranial pressure (ICP) is provided. A numerical model such as finite element model is developed in order to calculate the ICP, strain or stress for patients who suffers from hematoma, edema or tumor. The method can further provide local maximum principle strain that can provide information about possible subsequent brain injury, such as diffuse axonal injury, in sensitive region of the brain. Based on computer tomography or magnetic resonance images an individual diagnosis and treatment plan can be formed for each patient.
Owner:NIBIE

Device and method for protecting an ear of a subject from auricular haematoma

A device for protecting an ear of a subject from auricular haematoma, characterized in that the device comprises an inner member for inserting behind the ear and between the ear and skull of the subject, and a first outer member for placing over the ear of the subject, and for securing to the skull of the subject, the inner member being of a resilient shock absorbing material for acting as a shock absorber between the ear and skull and for cushioning the ear against the skull in the event of a blow, or other force, to the ear.
Owner:GOULDING BRIAN MICHAEL

Transcorporeal spinal decompression and repair systems and related methods

A system and method are provided for making an access channel through a vertebral body to access a site of neural compression, decompressing it, and repairing the channel to restore vertebral integrity. System elements include an implantable vertebral plate, a guidance device for orienting bone cutting tools and controlling the path of a cutting tool, a bone cutting tool to make a channel in the vertebral body, a tool for opening or partially-resecting the posterior longitudinal ligament of the spine, a tool for retrieving a herniated disc, an implantable device with osteogenic material to fill the access channel, and a retention device that lockably-engages the bone plate to retain it in position after insertion. System elements may be included in a surgery to decompress an individual nerve root, the spinal cord, or the cauda equina when compressed, for example, by any of a herniated disc, an osteophyte, a thickened ligament arising from degenerative changes within the spine, a hematoma, or a tumor.
Owner:GLOBUS MEDICAL INC

Transcorporeal spinal decompression and repair system and related method

A system and method are provided for making an access channel through a vertebral body to access a site of neural compression, decompressing it, and repairing the channel to restore vertebral integrity. System elements include an implantable vertebral plate, a guidance device for orienting bone cutting tools and controlling the path of a cutting tool, a bone cutting tool to make a channel in the vertebral body, a tool for opening or partially-resecting the posterior longitudinal ligament of the spine, a tool for retrieving a herniated disc, an implantable device with osteogenic material to fill the access channel, and a retention device that lockably-engages the bone plate to retain it in position after insertion. System elements may be included in a surgery to decompress an individual nerve root, the spinal cord, or the cauda equina when compressed, for example, by any of a herniated disc, an osteophyte, a thickened ligament arising from degenerative changes within the spine, a hematoma, or a tumor.
Owner:GLOBUS MEDICAL INC

Bicortical tibial fixation of ACL grafts

InactiveUSRE42526E1Minimize damageGood healing environmentLigamentsMusclesBone tunnelTibia
A method of securing a graft in a bone tunnel, in which graft is secured within the tunnel at both the entrance and the exit ends of the tunnel to provide bicortical fixation of the graft in the bone. Interference screws or other fixation devices are used to secure the graft within the tunnel. For tibial tunnel fixation using an interference screw, the back end of the distal screw is angled so that it closely approximates the angle of the outer tibial tunnel rim. The distal screw is non-cannulated to prevent hematomas from being formed by blood flowing from the tibial tunnel into the surrounding soft tissue. The proximal screw has a restricted cannula to minimize the flow of synovial fluid entering the tibial tunnel. Advantageously, the space between the two screws fills with blood to promote faster healing and incorporation of the graft in the tibial tunnel.
Owner:ARTHREX

Chinese medicine composition for treating cerebral hemorrhage and its prepn

The present invention is one kind of Chinese medicine composition for treating cerebral hemorrhage and is preparation process. The Chinese medicine composition consists of effective components from motherwort, giant knotweed, leech, gentian, and buffalo horn or rhinoceros horn; and may be prepared into medicine powder, tincture, capsule, tablet, micro pill and other forms. The Chinese medicine composition has the function of promoting blood circulation to disperse blood clots, and can alleviate hemorrhagic apoplexy cerebral edema, promote the absorption of hematoma and disease focus repair, improve the ischemic and anoxic state of nerve tissue around hematoma, protect damaged brain cell and promote restoring of the nerve function.
Owner:GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE

Intracranial hemorrhage early-stage hematoma minimally invasive elimination system

InactiveCN102973305AReduced entry caliberEasy accessSurgeryINTRACRANIAL EPIDURAL HEMORRHAGEMechanical crushing
The invention discloses an intracranial hemorrhage early-stage hematoma minimally invasive elimination system, comprising a puncture catheter system and a hematoma ultrasonic crushing mechanism, wherein the puncture catheter system comprises a puncture catheter body and a puncture needle core which is movably sleeved inside the puncture catheter body; an internal diameter of the puncture catheter body is 4-5 mm; a suction branch pipe is arranged at the position of the puncture catheter body, which is close to the tail end of the puncture catheter body; a sealing cover is mounted on the pipe opening of the suction branch pipe; the front end of the puncture needle core is bullet-shaped, and extends out the front end of the catheter body; the hematoma ultrasonic crushing mechanism comprises an ultrasonic crushing vibrator and an ultrasonic vibration rod connected with the ultrasonic crushing vibrator; the ultrasonic vibration rod is more than the puncture catheter body in length; and a thread is arranged at the front part of the ultrasonic vibration rod. The intracranial hemorrhage early-stage hematoma minimally invasive elimination system provided by the invention is simple in structure; and the puncture catheter body can conveniently puncture a catheter into a cranium, and is difficult to block. Compared with the conventional puncture catheter, the intracranial hemorrhage early-stage hematoma minimally invasive elimination system can more easily and naturally lead hematoma, so that the damage and the haemorrhage on brain tissues by the conventional mechanical crushing can be avoided.
Owner:THE FIRST AFFILIATED HOSPITAL OF THIRD MILITARY MEDICAL UNIVERSITY OF PLA

Use of onion extracts to prevent and treat acute and chronic cardiac and vascular complications and their sequelae, as well as to resolve hematomas

Onions (Allium Cepa and its close relatives, as opposed to Allium Sativum) contain potent coagulation modulators, as well as platelet inhibitors. Clinical, in vivo and in vitro testing confirms that the efficacy of commonly consumed quantities of onions in terms of the efficacy of its impact on coagulation and platelet function rivals and in many respects exceeds the potency of any other modalities available today. Additionally, onion compounds have unique effects as described later in this application. The use of onion extracts is thus proposed to prevent and treat acute and chronic cardiac and vascular complications and their sequelae, to prevent and treat thrombosis, to prevent and treat embolization in the setting of thrombosis, various arrhythmias and cardiac abnormalities, as well as to resolve hematomas
Owner:MADY ATTILA +1

Ointment of natural hirudin

Disclosed is a natural hirudin ointment, wherein the formula contains natural hirudin and conventional ointment matrix, and each 100g of the ointment contains natural hirudin 100-200000 international units. The ointment can be used for treating thrombotic phlebitis, burns, skin cracks, skin ulcer, chilblain, acne, acne and hemorrhoid.
Owner:周维海

Acupuncture method and device combining ultrasonic vibration with traditional acupuncture

ActiveCN109363929AAddress or avoid ultrasound doseFix or avoid frequencyAcupunctureDevices using mechanical vibrationsVibration amplitudeAcupuncture treatment
The invention discloses an acupuncture method and device combining ultrasonic vibration with traditional acupuncture, and relates to the technical field of ultrasonic treatment. The method comprises the steps that ultrasonic waves excited by a frequency conversion ultrasonic wave function generator are transmitted to an acupuncture needle, the syringe needle of the acupuncture needle generates longitudinal vibration or torsional vibration or bending vibration or longitudinal and torsional compounding vibration under the effect of ultrasonic waves, and by controlling the ultrasonic modal, the ultrasonic dosage, the ultrasonic frequency, the ultrasonic intensity, ultrasonic waveforms, acting time and the like, acupuncture points are stimulated to generate a certain physiological reaction toachieve the treatment effect. The device comprises the frequency conversion ultrasonic wave function generator, a time delay, a piezoelectric transducer, an amplitude transformer and the acupuncture needle; according to the method and device, no large-amplitude motion needs to be performed by means of the acupuncture needle, only micro-meter-scale vibration amplitude is generated under ultrasonicvibration, the problems of fainting during acupuncture treatment, needle sticking in acupuncture, needle bending, needle breaking, hematoma and the like during traditional needle manipulation are reduced, the problem that the effect of an existing ultrasonic acupuncture simulation method is not obvious is solved, and the good practical value is achieved.
Owner:JIANGSU UNIV

Disposable prepuce circularly cutting and suturing device

The prepuce circularly cutting and suturing device is surgical operation equipment for cutting redundant prepuce and suturing the cut edge, and the operation process is superior to available circumcision. The prepuce circularly cutting and suturing device of the present invention consists of cutting stage link rod, circular cutter link rod, nail bin driving link rod, circular cutter driving pinch plate, nail bin driving shift rod releasing pinch plate, circular cutter, nail bin assembly, cutting stage, gun, nail bin driving rod withdrawing head, and cutting stage regulating screw. The present invention has the advantages of simple operation, short operation period, no bleeding, no pain, no dropsy, no hematoma, tide cut edge, proper reserved prepuce length and being suitable for both adult and child.
Owner:黄新添

Method for non-invasive clinical monitoring intracranial edema

A method for clinically monitoring the intracranial edema without wound is disclosed. A low-frequency electric current flows through the craniocerebral surface to generate a current field. When the tissue structure in the current field changes, the electric current field is redistributed to reflect the change of intracranial edema, which is detected by phase change and displayed by computer and display device.
Owner:CHONG QING BORN FUKE MEDICAL EQUIP CO LTD

Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases

The invention discloses a traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases, which is prepared from the following bulk drugs: leech, lumbricus, scorpio and pseudo-ginseng. The traditional Chinese medicine composition disclosed by the invention accords with the theories of traditional Chinese medicine pharmacology of removing stasis, promoting new and self-quenching wind through blood circulation; in addition, by utilizing the traditional Chinese medicine composition formula, the traditional Chinese medicine composition disclosed by the invention is capable of promoting circulation, removing stasis, removing blood stasis, clearing hematoma, stopping rehaemorrhagia, reducing intracranial pressure, eliminating encephaledema, adjusting whole-body blood, resisting stress reaction and improving microcirculation and has the unique curative effects to perennial serious hypertension, cerebral hemorrhage, stroke, coronary heart disease and cerebral thrombosis.
Owner:谢国清

Elastic pressure hemostatic dressing

InactiveCN104490527AHas a dual oppressive structureDual compression structure does not requireNon-adhesive dressingsSurgeryElastic compressionDouble compression
The invention belongs to the technical field of medical appliances and particularly relates to an elastic pressure hemostatic dressing comprising a viscose elastic compression layer, the vicious side of the viscose elastic compression layer is connected with a first cushion layer, and a self-expansion layer is connected to the top end face of the first cushion layer. The elastic pressure hemostatic dressing has the advantages that the dressing is in a double-compression structure, strapping is not required, no movement occurs, hemostasis is efficient, and chances of bleeding and hematoma are slimed.
Owner:ZHEJIANG LONGTERM MEDICAL TECH CO LTD

Sodium aescinate toothpaste and preparation method thereof

The invention discloses sodium aescinate toothpaste and relates to the technical field of daily chemical products. The toothpaste disclosed by the invention comprises the following components in percentage by weight: 0.05%-2% of sodium aescinate, 20-55% of a friction agent, 20-30% of a moisturizing agent, 2-3% of a surfactant, 1-2% of a thickening agent, 0.05-0.25% of a sweetener, 0.05-0.5% of a preservative, 1-2% of essence, other special ingredients and the balance of water, and sodium aescinate toothpaste is prepared from the components by one of an intermittent two-step paste making method, a dry process one-step paste making method and a wet process one-step paste making method. The toothpaste disclosed by the invention has anti-inflammatory, detumescent and anti-exudation effects, and can be used for improving micro-circulation, promoting dissolution and absorption of hematoma, and well preventing and treating bleeding, swelling and halitosis caused by gum swelling and pain; and the toothpaste does not pass through a gastrointestinal tract and blood circulation, so that adverse reactions can be avoided and safety is realized.
Owner:FUJIAN MINDONG REJUVENATION PHARMA

Fetal head aspirator

InactiveCN107049446AImprove contact wearImprove blistersObstetrical instrumentsBruiseIntracranial Hemorrhages
The invention discloses a fetal head aspirator, and mainly relates to the field of obstetric apparatuses. The fetal head aspirator comprises a metal conical cylinder, the wide end of the conical cylinder is provided with multiple steel wire keels in arc fixed shapes, the inner sides of the top ends of the steel wire keels are provided with silica gel beads connected with the steel wire keels in a rolling mode, the outer sides of the steel wire keels are covered with negative pressure covers, the top sides of the negative pressure covers are provided with sealing edges, the top sides of the sealing edges bend inward, the negative pressure covers and the sealing edges are silica gel film which is formed integrally, the narrow end of the conical cylinder is provided with a connecting cylinder, the inner wall of the connecting cylinder is provided with an inner valve cavity provided with a one-way air valve, the outer wall of the connecting cylinder is provided with an air pumping nozzle used for pumping air and introducing air, and the air pumping nozzle is communicated with the inner valve cavity. The fetal head aspirator has the advantages of remarkably lowering the size of arching of afterbirth, remarkably solving the problems of fetal head scalp blister, bruises, lacerations, hematoma under the skin and under the periosteum, intracranial hemorrhage and the like, effectively assisting in delivery and childbirth, and protecting the health of fetuses.
Owner:柳荣华

Hemorrhoids treatment apparatus and operating method thereof

The invention relates to a hemorrhoids treatment apparatus and an operating method of the hemorrhoids treatment apparatus. The hemorrhoids treatment apparatus comprises a permanent magnet or an electromagnet, a motor for driving the permanent magnet or the electromagnet to rotate, and a sleeve sleeving the permanent magnet or the electromagnet. In use of the hemorrhoids treatment apparatus, the sleeve is sleeved by a sanitary sleeve, hemorrhoids-treating ointment is applied to the sanitary sleeve, then the sleeve is inserted into the anus, the motor is started for driving the permanent magnet or the electromagnet to rotate, and then the rotation magnet-therapy treatment is carried out on the hemorrhoids. The rotation magnet therapy has the efficacies that an alternating magnetic field output from the sleeve enables the human body cells to generate induction, so that the cell membrane potential is changed, then the membrane depolarization effect is generated, thus the permeability of tissue cells is enhanced, consequently, the cell arrangement is in order, and finally, the effective absorption of the local inflamed tissue for hematomas and edema exudation is facilitated. The four different physical therapy methods including rotation magnet-therapy treatment, hot compress treatment, vibratory massage treatment and 650NM laser treatment are adopted, and ani sphincter administration is also matched for carrying out comprehensive treatment on the internal and external hemorrhoids inflammation.
Owner:朱建春

Strontium chondroitin sulfate and preparation method thereof

The invention relates to strontium chondroitin sulfate and a preparation method thereof. The molecular formula of the strontium chondroitin sulfate is H2O(C14H19NSrO14S)x, wherein x is an integer of 60-100. According to the strontium chondroitin sulfate, the problems of petechiae and hematoma caused by calcium deposition of blood vessel parts and blood capillary parts can be avoided, and osteoporosis and osteoarthritis can be better treated in an aid way.
Owner:SOUTH UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA

Application of N6022 in prevention and treatment of aortic dissection and aortic aneurysm

ActiveCN111529524AInhibition of pathological expansionImprove the condition of the lesionOrganic active ingredientsCardiovascular disorderIntramural hematomaBlood vessel
The invention discloses application of N6022 in treatment of aortic dissection and aortic aneurysm, and relates to the field of cardiovascular diseases. In mouse models of aortic dissection and aorticaneurysm, dilation of aorta can be inhibited after intravenous injection of the N6022 into tail veins, thereby reducing incidence and mortality of aortic dissection and aortic aneurysm; and moreover,the N6022 is capable of reducing rupture of aortic aneurysm, inhibiting occurrence of hematoma in inner walls of lumen and excessive collagen deposition on vascular walls, maintaining integrity of elastic fibers in the vascular walls, and treating the aortic dissection and the aortic aneurysm. The application of the N6022 in the treatment of the aortic dissection and the aortic aneurysm opens upa new application field of the N6022, and provides a meaningful reference for the prevention and the treatment of the aortic dissection and the aortic aneurysm diseases as well as improvement of vascular lesions.
Owner:NANJING MEDICAL UNIV

Plaster for topical use containing heparin and diclofenac

Plaster for topical use having an analgesic activity and at the same time being able to re-absorb haematomas, comprising: a substrate layer; an adhesive layer in the form of a hydrogel matrix containing a pharmaceutically acceptable diclofenac salt, heparin or a heparinoid; a protective film which can be removed at the moment of use.
Owner:DONATI ELISABETTA +1

Internal and external medical closure screen systems and methods

An internal and external medical closure system for a separation of first and second tissue portions is provided, which includes a mesh screen comprising tubular vertical risers, vertical strands with barbed filaments, and horizontal spacers connecting the risers and strands in a grid-like configuration. An optional perimeter member partly surrounds the screen and can comprise a perimeter tube fluidically coupled with the vertical risers to form a tubing assembly. Various input / output devices can optionally be connected to the perimeter tube ends for irrigating and / or draining the separation according to methodologies of the present invention. Separation closure, irrigation and drainage methodologies are disclosed utilizing various combinations of closure screens, tubing, sutures, fluid transfer elements and gradient force sources. The use of mechanical forces associated with barbed strands for repositionably securing separated tissues together is disclosed. The use of same for eliminating or reducing the formation of subcutaneous voids or pockets, which can potentially form hematoma and seroma effects, is also disclosed. Further disclosed are alternative embodiment medical closure screen installation systems and methods.
Owner:3M INNOVATIVE PROPERTIES CO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products